TY - JOUR
T1 - Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy
AU - Samuels, Noah
AU - Ben-Arye, Eran
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Purpose of Review: Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of cancer treatment, with conventional treatment limited in its ability for prevention or treatment of symptoms. This review addresses the research assessing the effectiveness and safety of complementary and integrative medicine (CIM) in preventing and treating CIPN-related symptoms. Recent Findings: The CIM modalities acupuncture, classical massage, omega-3 fatty acids, and the Japanese Kampo medicine Goshanjishen may be of benefit in preventing or treating CIPN. Vitamin E (alpha-tocopherol), glutamine/glutamate, alpha-lipoic acid, and acetyl-l-carnitine (ALCAR) are not, with ALCAR increasing symptom severity and vitamin E the risk for developing prostate cancer. Summary: CIM therapies with a potential for preventing or treating CIPN-related symptoms should be further investigated. CIM is considered safe when provided within an integrative oncology setting, under the guidance and supervision of an integrative physician.
AB - Purpose of Review: Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication of cancer treatment, with conventional treatment limited in its ability for prevention or treatment of symptoms. This review addresses the research assessing the effectiveness and safety of complementary and integrative medicine (CIM) in preventing and treating CIPN-related symptoms. Recent Findings: The CIM modalities acupuncture, classical massage, omega-3 fatty acids, and the Japanese Kampo medicine Goshanjishen may be of benefit in preventing or treating CIPN. Vitamin E (alpha-tocopherol), glutamine/glutamate, alpha-lipoic acid, and acetyl-l-carnitine (ALCAR) are not, with ALCAR increasing symptom severity and vitamin E the risk for developing prostate cancer. Summary: CIM therapies with a potential for preventing or treating CIPN-related symptoms should be further investigated. CIM is considered safe when provided within an integrative oncology setting, under the guidance and supervision of an integrative physician.
KW - Acupuncture
KW - Chemotherapy-induced neuropathy
KW - Complementary and integrative medicine
KW - Dietary supplements
KW - Touch therapies
UR - http://www.scopus.com/inward/record.url?scp=85079338262&partnerID=8YFLogxK
U2 - 10.1007/s11912-020-0891-2
DO - 10.1007/s11912-020-0891-2
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 32048067
AN - SCOPUS:85079338262
SN - 1523-3790
VL - 22
JO - Current Oncology Reports
JF - Current Oncology Reports
IS - 3
M1 - 23
ER -